News
The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...
Studies have shown that GLP-1s reduce inflammation in the brain and regulate anxiety as well as depression. When insurance ...
We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the ...
23h
MarketBeat on MSNBest Biotech Stocks to Buy in 2025The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered ...
Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and changing regulatory requirements by expanding its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results